Compare J.B.Chemicals with Lupin - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs LUPIN - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

LUPIN 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS LUPIN J.B.CHEMICALS/
LUPIN
 
P/E (TTM) x 49.3 46.7 105.5% View Chart
P/BV x 9.2 4.3 213.5% View Chart
Dividend Yield % 0.1 0.5 25.4%  

Financials

 J.B.CHEMICALS   LUPIN
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
LUPIN
Mar-20
J.B.CHEMICALS/
LUPIN
5-Yr Chart
Click to enlarge
High Rs363882 41.2%   
Low Rs255505 50.5%   
Sales per share (Unadj.) Rs169.1339.4 49.8%  
Earnings per share (Unadj.) Rs16.6-5.9 -279.1%  
Cash flow per share (Unadj.) Rs23.415.5 151.4%  
Dividends per share (Unadj.) Rs2.006.00 33.3%  
Dividend yield (eoy) %0.60.9 74.8%  
Book value per share (Unadj.) Rs172.5276.7 62.3%  
Shares outstanding (eoy) m83.57453.00 18.4%   
Bonus / Rights / Conversions BBESOP-  
Price / Sales ratio x1.82.0 89.4%   
Avg P/E ratio x18.6-116.6 -16.0%  
P/CF ratio (eoy) x13.244.8 29.4%  
Price / Book Value ratio x1.82.5 71.5%  
Dividend payout %12.0-100.9 -11.9%   
Avg Mkt Cap Rs m25,827314,201 8.2%   
No. of employees `0003.818.3 20.6%   
Total wages/salary Rs m2,51129,868 8.4%   
Avg. sales/employee Rs Th3,747.48,400.6 44.6%   
Avg. wages/employee Rs Th665.71,632.0 40.8%   
Avg. net profit/employee Rs Th367.8-147.2 -249.9%   
INCOME DATA
Net Sales Rs m14,135153,748 9.2%  
Other income Rs m3664,838 7.6%   
Total revenues Rs m14,501158,585 9.1%   
Gross profit Rs m2,17824,849 8.8%  
Depreciation Rs m5709,702 5.9%   
Interest Rs m353,630 1.0%   
Profit before tax Rs m1,94016,355 11.9%   
Minority Interest Rs m04 0.0%   
Prior Period Items Rs m039 0.0%   
Extraordinary Inc (Exp) Rs m0-7,521 0.0%   
Tax Rs m55211,571 4.8%   
Profit after tax Rs m1,387-2,694 -51.5%  
Gross profit margin %15.416.2 95.3%  
Effective tax rate %28.570.8 40.2%   
Net profit margin %9.8-1.8 -560.1%  
BALANCE SHEET DATA
Current assets Rs m10,470154,132 6.8%   
Current liabilities Rs m2,74992,252 3.0%   
Net working cap to sales %54.640.2 135.7%  
Current ratio x3.81.7 228.0%  
Inventory Days Days5582 67.2%  
Debtors Days Days78129 60.1%  
Net fixed assets Rs m5,81189,082 6.5%   
Share capital Rs m167906 18.4%   
"Free" reserves Rs m14,248124,461 11.4%   
Net worth Rs m14,416125,367 11.5%   
Long term debt Rs m017,933 0.0%   
Total assets Rs m17,649249,839 7.1%  
Interest coverage x56.65.5 1,027.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.6 130.1%   
Return on assets %8.10.4 2,151.0%  
Return on equity %9.6-2.1 -447.8%  
Return on capital %13.78.7 156.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16451,450 12.0%   
Fx outflow Rs m1,33419,470 6.9%   
Net fx Rs m4,82931,980 15.1%   
CASH FLOW
From Operations Rs m1,23114,688 8.4%  
From Investments Rs m-20811,070 -1.9%  
From Financial Activity Rs m-595-8,906 6.7%  
Net Cashflow Rs m42716,853 2.5%  

Share Holding

Indian Promoters % 55.4 46.6 118.9%  
Foreign collaborators % 0.3 0.2 150.0%  
Indian inst/Mut Fund % 3.4 11.3 30.0%  
FIIs % 3.9 31.9 12.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.1 366.3%  
Shareholders   30,437 98,259 31.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   VENUS REMEDIES  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  NEULAND LABS  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 300 Points, Nifty Below 15,700; Adani Group Stocks Tumble(09:30 am)

Asian stock markets are mixed today in holiday-thinned trading as investors prepared for a key Federal Reserve meeting later in the week.

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules(Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Rs 2 Trillion Stimulus Coming to a Stock Market Near You(Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 14, 2021 10:20 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS